cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Jose G GuillemSalvatore Pucciarelli

Abstract

Although combined-modality therapy (CMT) is the preferred treatment for T3 and/or lymph node (LN)-positive rectal cancer, the German rectal cancer study published in 2004 demonstrated that 18% of patients deemed suitable for preoperative CMT by endorectal ultrasound (ERUS) may be overstaged. Because data also suggest that LN-negative rectal cancer after total mesorectal excision may not require radiotherapy, it is reasonable to consider omitting radiotherapy for the cT3N0 subset. We therefore determined the accuracy of pre-CMT ERUS or magnetic resonance imaging (MRI) staging, to explore the validity of a nonpreoperative CMT approach for cT3N0 disease. One hundred eighty-eight ERUS-/MRI-staged T3N0 rectal cancer patients received preoperative CMT (fluorouracil based and 45-50.4 Gy) followed by radical resection. Rates of pathologic complete response (pCR) and mesorectal LN involvement were determined. Tumors were located a median of 5 cm from the anal verge. Sphincter-preserving surgery was performed in 143 patients (76%). Overall pCR was 20%, and 41 patients (22%) had pathologically positive mesorectal LNs. The incidence of positive LNs significantly increased with T stage: ypT0, 3%; ypT1, 7%; ypT2, 20%; ypT3-4, 36% (P = .001)....Continue Reading

References

Jan 1, 1985·Diseases of the Colon and Rectum·U Hildebrandt, G Feifel
Jan 1, 1993·Diseases of the Colon and Rectum·J B GreenJ E Ray
Feb 1, 1993·Diseases of the Colon and Rectum·M J Solomon, R S McLeod
May 16, 1998·Journal of the American College of Surgeons·D BlumbergA M Cohen
Sep 25, 1999·Diseases of the Colon and Rectum·A NissanA M Cohen
Dec 20, 1999·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·N B MerchantA M Cohen
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Y FrancoisJ P Gerard
Apr 15, 2000·International Journal of Colorectal Disease·H KwokG L Hill
Apr 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C A MarijnenUNKNOWN Pathology Review Committee and the Cooperative Clinical Investigators
Jan 12, 2002·Diseases of the Colon and Rectum·Julio Garcia-AguilarRobert D Madoff
Mar 5, 2002·Archives of Surgery·Matthias W WichmannFriedrich W Schildberg
Jun 26, 2002·The Journal of Pathology·Iris D NagtegaalUNKNOWN Pathology Review Committee
Jun 20, 2003·The New England Journal of Medicine·Mukesh G HarisinghaniRalph Weissleder
Aug 9, 2003·International Journal of Colorectal Disease·R G H Beets-Tan, G L Beets
Oct 31, 2003·Seminars in Radiation Oncology·Dushyant V SahaniPeter F Hahn
Feb 11, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frederick L GreeneH James Norton
Apr 7, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard L GundersonRichard M Goldberg
Aug 3, 2004·Clinical Colorectal Cancer·David M Schaffzin, W Douglas Wong
Sep 24, 2004·European Journal of Radiology·Joo Hee KimRegina G H Beets-Tan
Oct 22, 2004·The New England Journal of Medicine·Rolf SauerUNKNOWN German Rectal Cancer Study Group
Jan 26, 2005·International Journal of Radiation Oncology, Biology, Physics·Nancy N BaxterJoel E Tepper
May 4, 2005·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Hanns-Peter KnaebelPeter Kienle
Sep 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Aviram NissanW Douglas Wong

❮ Previous
Next ❯

Citations

Feb 26, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Luca Tagliabue
Nov 1, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R MaréchalJ L Van Laethem
Jun 9, 2010·The Cancer Journal·Bruce D MinskyVincenzo Valentini
Jan 18, 2011·Annals of Surgery·Doenja M J LambregtsRegina G H Beets-Tan
Jul 22, 2010·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·S Gollins
Feb 2, 2012·Chemotherapy Research and Practice·Ingrid GarajováGiovanni Brandi
Sep 26, 2012·Radiation Oncology·William E JonesW Warren Suh
Jun 28, 2011·Annals of Surgical Oncology·Marco Zoccali, Alessandro Fichera
Apr 13, 2011·World Journal of Gastroenterology : WJG·Jose M Enríquez-NavascuésLuis Bujanda
Nov 1, 2012·World Journal of Gastroenterology : WJG·Atthaphorn TrakarnsangaMartin R Weiser
Feb 22, 2012·Annals of Surgical Oncology·Sebastian G de la FuenteChristopher R Mantyh
Dec 17, 2009·Annals of Surgical Oncology·Raffaele LombardiBruno Cola
Nov 13, 2013·International Journal of Clinical Oncology·Deniz TuralSüheyla Serdengeçti
Dec 6, 2014·Hematology/oncology Clinics of North America·Emily K Bergsland
Jan 27, 2011·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Dietmar OfnerUNKNOWN TAKO 05/ABCSG R-02 Trial Investigators
Mar 10, 2012·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·J WinklerF Zimmermann
Mar 10, 2010·World Journal of Surgery·Claudio FuciniAntonio Russo
Oct 29, 2010·Medizinische Klinik·Nicole Jacobi, Frank Gieseler
Dec 15, 2015·Expert Review of Anticancer Therapy·Subotheni Thavaneswaran, Timothy J Price
Nov 26, 2013·Surgical Oncology Clinics of North America·P Terry Phang, Xiaodong Wang
Nov 19, 2013·Magnetic Resonance Imaging Clinics of North America·Michael R TorkzadRegina G H Beets-Tan
Nov 28, 2012·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·B De BariV Valentini
Sep 1, 2010·Insights Into Imaging·Michael R TorkzadBengt Glimelius
Dec 14, 2011·Clinical Colorectal Cancer·Sarah PopekAlfred M Cohen
Oct 5, 2011·Clinical Oncology : a Journal of the Royal College of Radiologists·J J JobsenJ W W Coebergh
Oct 7, 2011·Clinical Colorectal Cancer·Bruce D Minsky
Sep 14, 2011·Surgical Oncology·P E ColomboP Rouanet
Aug 4, 2011·Seminars in Oncology·Bruce D Minsky
Jun 8, 2011·Seminars in Radiation Oncology·Jennifer Y WoTheodore S Hong
Oct 5, 2010·Surgical Oncology Clinics of North America·Geerard L Beets, Regina G H Beets-Tan
Oct 5, 2010·Surgical Oncology Clinics of North America·Julio Garcia-Aguilar, Alicia Holt
Oct 5, 2010·Surgical Oncology Clinics of North America·Bruce D Minsky
Oct 5, 2010·Surgical Oncology Clinics of North America·Angelita Habr-GamaJoaquim Gama-Rodrigues
Jul 8, 2010·International Journal of Radiation Oncology, Biology, Physics·Hendrik EveraertMark De Ridder
Apr 24, 2010·Cirugía española·Guillermo Ais CondeJavier Manzanares Sacristán

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.